Evidence map›Paper›PMID 36095303›Full record

ArticleBlood advances2023

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

Ramón Diez-Feijóo, Concepción Fernández-Rodríguez, Marta Lafuente, Nieves García-Gisbert, Ana Ferrer, Luis Colomo, Marta Salido, Antonio Salar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ramón Diez-FeijóoDepartment of Hematology, Hospital del Mar, Barcelona, Spain.
Concepción Fernández-RodríguezGroup of Applied Clinical Research in Hematology, Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Marta LafuenteGroup of Applied Clinical Research in Hematology, Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Nieves García-GisbertGroup of Applied Clinical Research in Hematology, Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.ORCID 0000-0002-8185-9786
Ana FerrerDepartment of Pathology, Hospital del Mar, Barcelona, Spain.ORCID 0000-0002-3381-9472
Luis ColomoDepartment of Pathology, Hospital del Mar, Barcelona, Spain.ORCID 0000-0001-5236-5085
Marta SalidoDepartment of Pathology, Hospital del Mar, Barcelona, Spain.ORCID 0000-0001-9988-5977
Antonio SalarDepartment of Hematology, Hospital del Mar, Barcelona, Spain.ORCID 0000-0002-4652-4825
Hospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-Cell, Marginal ZoneTranslocation, GeneticCaspasesHumansRNA-Binding ProteinsCaspasesIGF2BP2 protein, humanRNA-Binding Proteins

Identifiers

PMID36095303
PMCPMC9811198
OpenAlexW4295508198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.